New Product 'Anti-Mammary Hyperplasia Capsule'Enter Phase III Clinical Trials, Boosting Breast Health

31, Jul. 2025

The New Product ‘Anti-Mammary Hyperplasia Capsule’ self-developed by Heilongjiang Tianlong Pharmaceutical Co.,Ltd.is in Phase Ⅲ Clinical Test.

 

Recently, the Anti-Mammary Hyperplasia Capsule, independently developed by Heilongjiang Tianlong Pharmaceutical, have officially entered the Phase III clinical trial stage, marking a significant step forward in the treatment of mammary gland hyperplasia.

 

New Product 'Anti-Mammary Hyperplasia Capsule'Enter Phase III Clinical Trials, Boosting Breast Health

 

Anti-Mammary Hyperplasia Capsule is a new traditional Chinese medicine developed by Heilongjiang Tianlong Pharmaceutical over many years, primarily used for the treatment of mammary gland hyperplasia. ‘Anti-Mammary Hyperplasia Capsule’ is a 100% herbal medicine. It can not only effectively treat mammary gland hyperplasia and, to some extent, inhibit the development of breast cancer. Guided by traditional Chinese medicine theory and combined with modern pharmaceutical technology, the drug is made from a selection of authentic medicinal materials. It has the effects of soothing the liver, regulating qi, promoting blood circulation, removing blood stasis, and softening hard lumps.

 

New Product 'Anti-Mammary Hyperplasia Capsule'Enter Phase III Clinical Trials, Boosting Breast Health

 

Heilongjiang Tianlong Pharmaceutical has always adhered to the corporate idea of "serving the people and curing diseases," committed to providing patients with safe, effective, and quality-controlled medicines. During the development of Anti-Mammary Hyperplasia Capsule, the company strictly followed the relevant regulations of the National Medical Products Administration, conducting comprehensive pharmaceutical, pharmacological, toxicological, and clinical studies to ensure the safety and efficacy of the drug.

 

The entry of Anti-Mammary Hyperplasia Capsule into Phase III clinical trials is another significant achievement for Heilongjiang Tianlong Pharmaceutical in the field of innovative drug development. The company will continue to uphold the philosophy of "quality first,credit first," accelerate the clinical trial process of Anti-Mammary Hyperplasia Capsule , and strive for early market approval to bring good news to patients with mammary gland hyperplasia and contribute to the cause of human health.

 

New Product 'Anti-Mammary Hyperplasia Capsule'Enter Phase III Clinical Trials, Boosting Breast Health

 

About Heilongjiang Tianlong Pharmaceutical:

 

Heilongjiang Tianlong Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise integrating drug research and development, production, and sales. The company boasts advanced GMP production equipment and a comprehensive quality management system, with products covering traditional Chinese medicines, chemical drugs, biological drugs, and more. Tianlong Provides Suppository, Cream, Ointment, Lotion, Spray, Liniment, Gel, Drops, Solution etc, which are engaged in Gynecological, Dermatological, Pediatrics, Dental departments etc.

   

New Product 'Anti-Mammary Hyperplasia Capsule'Enter Phase III Clinical Trials, Boosting Breast Health
Whatsapp
New Product 'Anti-Mammary Hyperplasia Capsule'Enter Phase III Clinical Trials, Boosting Breast Health
Wechat